Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review.
FAP
Fibroblast activation protein
Fibroblasts
PET
PET-CT
Positron emission tomography
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
19 Feb 2021
19 Feb 2021
Historique:
received:
11
12
2020
accepted:
10
02
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
20
2
2021
Statut:
epublish
Résumé
Small molecules targeting fibroblast activation protein (FAP) have emerged as a new group of tracers for positron emission tomography (PET) in 2018. While most of the existing literature has been focussed on the application of FAP-specific PET in various kinds of cancers, some researchers have, both intentionally or unintentionally, used FAP-specific PET in patients with non-cancerous diseases. The purpose of this systematic review is therefore to summarize the available evidence of FAP-specific PET for non-malignant indications. The MEDLINE database was searched for studies presenting the clinical use of FAP-specific PET, the records were screened according to PRISMA guidelines and articles containing patients suffering from non-malignant diseases were included. Sixteen studies with 303 patients were included. FAP-specific PET has been used in cardiac imaging, IgG While publications on FAP-specific PET for non-malignant indications are mostly limited to case reports and incidental findings, the first retrospective and prospective studies present promising results for IgG
Identifiants
pubmed: 33606104
doi: 10.1186/s13550-021-00761-2
pii: 10.1186/s13550-021-00761-2
pmc: PMC7895887
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
18Références
Eur J Nucl Med Mol Imaging. 2020 Sep 8;:
pubmed: 32901354
Eur J Nucl Med Mol Imaging. 2020 Aug 28;:
pubmed: 32857182
Nuklearmedizin. 2019 Sep;58(5):371-378
pubmed: 31486054
Clin Nucl Med. 2021 Feb 1;46(2):e86-e87
pubmed: 32701818
J Nucl Med. 2020 Aug;61(8):1171-1177
pubmed: 31836685
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):196-203
pubmed: 32468254
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Clin Nucl Med. 2020 Apr;45(4):310-311
pubmed: 31977474
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2078-2079
pubmed: 32385646
J Clin Oncol. 2019 Jun 20;37(18):1558-1565
pubmed: 31067138
J Nucl Med. 2020 Apr;61(4):620
pubmed: 31420500
Ann Rheum Dis. 2020 Nov;79(11):1485-1491
pubmed: 32719042
AJR Am J Roentgenol. 2021 Feb;216(2):307-308
pubmed: 32755204
J Nucl Cardiol. 2020 Aug 16;:
pubmed: 32803676
JACC Cardiovasc Imaging. 2015 Dec;8(12):1466-1468
pubmed: 26699115
Circ Cardiovasc Imaging. 2020 Sep;13(9):e011603
pubmed: 32912028
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Analyst. 2019 Aug 5;144(16):4935-4942
pubmed: 31313760
Clin Nucl Med. 2020 Aug;45(8):632-635
pubmed: 32453079
J Mol Cell Cardiol. 2015 Oct;87:194-203
pubmed: 26319660
Eur Heart J. 2020 Mar 1;41(9):1060
pubmed: 31630152
Molecules. 2020 Aug 12;25(16):
pubmed: 32806623
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
Radiother Oncol. 2020 Sep;150:159-163
pubmed: 32598977
Clin Nucl Med. 2020 Nov;45(11):913-915
pubmed: 32910045
Clin Nucl Med. 2020 Jul;45(7):566-567
pubmed: 32371618
J Mater Chem B. 2018 Mar 14;6(10):1449-1451
pubmed: 32254208
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1820-1832
pubmed: 32222810
Clin Cancer Res. 2020 Sep 15;26(18):4882-4891
pubmed: 32636317
JACC Cardiovasc Imaging. 2015 Dec;8(12):1417-1426
pubmed: 26577262
Clin Nucl Med. 2020 Oct;45(10):784-786
pubmed: 32796242
Methods. 2020 May 7;:
pubmed: 32389748
Breast J. 2017 Jul;23(4):401-409
pubmed: 28117517
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):2040-2041
pubmed: 31814067
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580
pubmed: 31388723
Clin Nucl Med. 2020 Jun;45(6):468-470
pubmed: 32149789
Eur J Radiol. 2020 Jun;127:109021
pubmed: 32344293
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65
pubmed: 20159360
Circ Cardiovasc Imaging. 2020 Sep;13(9):e010628
pubmed: 32912030
Circ Res. 2016 Jun 10;118(12):1906-17
pubmed: 27140435
Rheumatology (Oxford). 2018 Apr 1;57(4):737-747
pubmed: 29361119
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2080-2082
pubmed: 32440890
EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19
pubmed: 32728930
J Nucl Cardiol. 2020 Sep 25;:
pubmed: 32975729
Data Brief. 2020 May 15;31:105712
pubmed: 32490080
J Nucl Med. 2021 Feb;62(2):201-207
pubmed: 32591493
Cancers (Basel). 2020 Sep 15;12(9):
pubmed: 32942573
Anal Chem. 2019 Aug 6;91(15):10197-10203
pubmed: 31264843
Eur J Nucl Med Mol Imaging. 2020 Jul 10;:
pubmed: 32651662
Clin Nucl Med. 2021 Feb 1;46(2):e78-e79
pubmed: 32804764
Clin Nucl Med. 2020 Oct;45(10):e430-e432
pubmed: 32332301
J Nucl Med. 2021 Feb;62(2):266-271
pubmed: 32513902
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):73-86
pubmed: 32588089
J Nucl Med. 2019 Dec;60(12):1743-1749
pubmed: 31405922
Clin Nucl Med. 2020 Apr;45(4):312-313
pubmed: 31977476
J Nucl Med. 2020 Sep;61(9):1331-1336
pubmed: 32060216
AJR Am J Roentgenol. 2021 Feb;216(2):305-306
pubmed: 32755205
JACC Cardiovasc Imaging. 2018 Oct;11(10):1541-1543
pubmed: 29454781
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2625-2626
pubmed: 31410541
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1754-1755
pubmed: 31119317
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):647-648
pubmed: 32632460
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):651-652
pubmed: 32643006
Theranostics. 2020 Apr 27;10(13):5778-5789
pubmed: 32483418